Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
Therapeutic Category
Antibacterials, Antibiotic, Pediatrics, ENT
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹149/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxyplit CV 228.5 Tablet is a broad-spectrum antibiotic combination that contains Amoxycillin, a penicillin-class antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. This combination enhances the effectiveness of Amoxycillin, making it more potent against a wider range of bacterial pathogens, including those that produce beta-lactamase, which would normally make the bacteria resistant to Amoxycillin.
Amoxycillin works by inhibiting the growth of bacteria through interference with the bacterial cell wall, ultimately leading to the bacteria’s death. Clavulanic Acid protects Amoxycillin from being broken down by beta-lactamase enzymes produced by resistant bacteria. Together, they provide a powerful treatment for a variety of bacterial infections.
Moxyplit CV 228.5 Tablet is commonly used to treat respiratory infections, urinary tract infections (UTIs), skin infections, and infections of the ear and sinuses. It is also effective for managing infections associated with dental procedures and for more serious infections, including intra-abdominal infections.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Moxyplit CV 228.5 Tablet Indicated for treating bacterial infections in the ear, nose, throat, lungs, urinary tract, skin, and drug-resistant tuberculosis in children.
Information regarding the use of Moxyplit CV Kid 228.5 Tablet during breastfeeding is not available. Please consult your doctor.
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Composition : Amoxycillin (250mg) + Clavulanic Acid (125mg)
Composition : Amoxycillin (400mg/5ml) + Clavulanic Acid (57mg/5ml)
Composition : Amoxycillin (80mg) + Clavulanic Acid (11.4mg) Drops
Composition : Amoxycillin Trihydrate I.P. 250mg + Cloxacillin I.P. 250mg + Lactic Acid Bacillus 1.7 Billion Spores
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus
Composition : Amoxycillin (500mg) + Clavulanic Acid (100mg)
Composition : Amoxycillin (500mg) + Clavulanic Acid (125mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This antibiotic combination tablet has strong demand in the anti-infective and pediatric care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on general medicine and child healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for treatment of respiratory tract infections, ear infections, throat infections, sinus infections, urinary tract infections, and other bacterial infections. Amoxycillin helps eliminate infection-causing bacteria, while Clavulanic Acid enhances antibiotic effectiveness by overcoming bacterial resistance, strengthening a reliable antibiotic product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this antibiotic combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong physician and pediatric prescription demand, fast-moving anti-infective category, seasonal infection sales growth, reliable supply chain support, and good margins when partnering for this antibiotic product.
Medical distributors, stockists, and wholesalers interested in this antibiotic combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.